CD4 and Sepsis: In addition, eCIRP can also activate CD4+ T lymphocytes and predispose CD4+ T cells to a Th1 hyperinflammatory response profile and CD8+ T cells to a cytotoxic response profile, thus promoting the inflammatory response in sepsis.21